Industry News
Biotechnology Industry News
UPDATE: After FDA hold, CytoDyn will appeal for pharma partnerships to save leronlimab
UPDATE: After FDA hold, CytoDyn will appeal for pharma partnerships to save leronlimab aarmstrong Wed, 03/30/2022 - 17:50
An FDA panel reviewing Amylyx’s ALS drug was moved by patient testimony—but they voted it down anyway
An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway aarmstrong Wed, 03/30/2022 - 16:26
2 gene editing biotechs team up to improve on delivery with $45 upfront
2 gene editing biotechs team up to improve on delivery with $45 upfront gmasson Wed, 03/30/2022 - 16:08
2 gene editing biotechs team up to improve on delivery with $45M upfront
2 gene editing biotechs team up to improve on delivery with $45M upfront gmasson Wed, 03/30/2022 - 16:08
EU regulators warn clinical trial changes ‘unavoidable’ in Ukraine due to Russian invasion
EU regulators warn clinical trial changes 'unavoidable' in Ukraine due to Russian invasion gmasson Wed, 03/30/2022 - 14:34
Athira drama not over yet, as investor and ally of former CEO calls for another C-suite change
Athira drama not over yet, as investor and ally of former CEO calls for another C-suite change aarmstrong Wed, 03/30/2022 - 13:19
GSK, CureVac hope 2nd time’s the charm as updated COVID vax launches into clinic
GSK, CureVac hope 2nd time's the charm as updated COVID vax launches into clinic mbayer Wed, 03/30/2022 - 10:45
Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal
Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal aarmstrong Wed, 03/30/2022 - 09:59
UPDATE: Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal
UPDATE: Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal aarmstrong Wed, 03/30/2022 - 09:59
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron? ntaylor Wed, 03/30/2022 - 08:03
Roche’s lung cancer gamble flames out as TIGIT digits come up short in phase 3
Roche's lung cancer gamble flames out as TIGIT digits come up short in phase 3 ntaylor Wed, 03/30/2022 - 05:10
Karyopharm hoping for some Keytruda stardust as former Merck & Co. exec joins as CMO
Karyopharm hoping for some Keytruda stardust as former Merck & Co. exec joins as CMO gmasson Tue, 03/29/2022 - 13:27
Outgoing NIAID vaccine R&D chief John Mascola reflects on leading ‘NASA-type incubator’
Outgoing NIAID vaccine R&D chief John Mascola reflects on leading 'NASA-type incubator' mbayer Tue, 03/29/2022 - 11:45
Cuts to the Bone: Orthopedic biotech slashes C-suite, overhauls entire pipeline
Cuts to the Bone: Orthopedic biotech slashes C-suite, overhauls entire pipeline mbayer Tue, 03/29/2022 - 10:26
Neuron23 snags $100M and a new Parkinson’s disease candidate
Neuron23 snags $100M and a new Parkinson's disease candidate ssorensen Tue, 03/29/2022 - 10:19
ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data
ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data aarmstrong Tue, 03/29/2022 - 09:34
Pfizer’s $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings ntaylor Tue, 03/29/2022 - 08:08
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact ntaylor Tue, 03/29/2022 - 05:58
Biden seeks $2.1B funding boost for FDA, part of pan-agency pandemic preparedness plan
Biden seeks $2.1B funding boost for FDA, part of pan-agency pandemic preparedness plan aarmstrong Mon, 03/28/2022 - 14:26
Amylyx to answer for single-study ALS application at FDA advisory panel
Amylyx to answer for single-study ALS application at FDA advisory panel aarmstrong Mon, 03/28/2022 - 10:47